What is 7-OH, and is it Dangerous?

Original clinical review: Christopher Diviaio, LCSW

Christopher DiViaio is a Licensed Clinical Social Worker with over a decade of experience supporting individuals, families, and groups through complex emotional and life challenges. Grounded in strong family values, Christopher believes that meaningful connection, stability, and mutual support are foundational to emotional health and long-term growth. Outside of his clinical work, Christopher is laid-back and values balance—he enjoys hiking, gaming, and tabletop strategy games like Warhammer. He is a proud husband and father of two, and he strives to model presence, curiosity, and resilience both at home and in his professional life. Christopher believes that staying connected to family, personal interests, and real-life experiences is essential to growth, emotional regulation, and overall well-being.

This attribution is retained from the existing published article. New or revised program information requires an updated clinical review before publication.

In recent years, the compound 7-hydroxymitragynine, commonly referred to as 7-OH, has gained attention due to its presence in kratom and its potential impact on public health. Often marketed in drink mixes, tablets, pills, fruit-flavored gummies, and even sold in vape stores, gas stations, and smoke shops, 7-OH is found in various kratom products and is believed to contribute to the opioid-like effects users experience. But what exactly is 7-OH? Where does it come from, and more importantly, is it dangerous?

This article explores the origins, pharmacology, risks, and legal concerns surrounding 7-OH — particularly within the context of the ongoing opioid crisis and rising health concerns related to unregulated substances.

What is 7-OH?

7-hydroxymitragynine (7-OH) is a naturally occurring indole alkaloid found in the kratom plant (Mitragyna speciosa), a tropical tree native to Southeast Asia.[1] While it is one of over 40 known alkaloids in kratom, 7-OH is particularly potent.

Although it is present in extremely low concentrations in the raw plant, 7-OH is a powerful active metabolite of mitragynine, the most abundant alkaloid in kratom. Through metabolism, particularly in the liver, mitragynine is converted into 7-OH, which binds strongly to opioid receptors, especially the mu-opioid receptor, mimicking the effects of morphine.

Medical and Pharmacological Profile

7-OH’s pharmacology is similar to traditional opioids, leading to analgesic (pain-relieving) and euphoric effects. It exhibits an antinociceptive effect, which makes it attractive to those seeking relief from pain, anxiety, or other ailments.

However, its affinity to opioid receptors raises red flags. It functions as a partial agonist, meaning it activates opioid receptors but not to the same extent as full agonists like heroin or fentanyl. Despite this, the ability of 7-OH to induce opioid-like effects is significant enough to prompt concern from public health authorities.

FDA describes 7-OH as substantially more potent at the mu-opioid receptor than mitragynine and morphine. A laboratory potency comparison is not a safe-dose conversion for people or a reliable comparison between retail products.

Source: FDA · kratom safety and approval status

Products Containing 7-OH

Commercial kratom products vary widely in their total alkaloid content, and many are concentrated during processing to enhance the effects. This can lead to high concentrations of 7-OH — far beyond what is naturally present in the plant.

Some products, such as drink mixes and shots, gummies, and even ice cream cones, have been found to contain elevated 7-OH levels, often unlabeled and unregulated. This creates a challenge for consumers who may unknowingly ingest dangerous doses.

Is 7-OH Dangerous?

7-OH is a potent opioid, and its health risks do not depend on whether a product is legally scheduled. FDA warns that concentrated products can cause dependence, withdrawal and overdose. They are not approved substitutes for opioid-use-disorder treatment.

Source: FDA · 7-OH consumer guide; product differences and safety (PDF)

Health Concerns and Adverse Events

According to the FDA (Food and Drug Administration) and the National Institute on Drug Abuse (NIDA), kratom has been linked to multiple adverse events, including:[3]

• Respiratory depression
• Liver toxicity
• Seizures
• Mood disorders
• Opioid withdrawal symptoms 

CDC’s April 2019 report covered July 2016–December 2017 overdose data from participating states: 152 deaths had kratom detected, and 91 listed kratom as a cause. Multiple substances were detected in almost all cases. The study did not establish an isolated 7-OH death count or show that 7-OH caused these deaths.

Source: CDC MMWR · April 2019; July 2016–December 2017 overdose data and limitations

The often-cited 1,807 kratom exposure reports were collected across 2011–2017, not during 2021 alone. The 2019 poison-center study concerns kratom reports, not a separately measured count of concentrated 7-OH cases.

Source: Post and colleagues · Clinical Toxicology, 2019; poison-center reports, 2011–2017

Link to Opioid Addiction and Withdrawal

One of the reasons 7-OH and kratom appeal to users is their perceived potential to treat opioid use disorder (OUD) and ease opioid withdrawal. Anecdotally, kratom users report self-managing addiction and withdrawal symptoms using kratom-based products.

While this may suggest a harm-reduction role, the science is mixed. Clinical evidence supporting kratom for OUD is lacking, and the risk of developing a new form of dependence on kratom and 7-OH is substantial. Repeated use may lead to tolerance, withdrawal, and eventual addiction, especially when 7-OH concentrations are elevated through synthetic processing.

Furthermore, studies suggest that 7-OH can be reversed by naloxone, an opioid receptor competitive antagonist, further supporting its opioid-like mechanism and reinforcing the potential for abuse and dependency.[6]

Regulatory Status and Legal Landscape

These products are not outside federal oversight. FDA’s July 13, 2026 update describes a temporary-scheduling process begun July 1 for concentrated 7-OH and certain synthetic derivatives. The stated target excludes natural leaf with trace 7-OH. That notice is not, by itself, proof that a final scheduling order has taken effect.

Source: FDA · 7-OH regulatory update, July 13, 2026; notice is not a final order

The FDA has not approved kratom or 7-OH for any medical use, warning that the marketing of these products is often misleading and illegal. The agency continues to push for more research and regulatory oversight.

Why 7-OH Is a Particular Concern

Several factors contribute to the increasing scrutiny of 7-OH:

1. Potency: It is significantly more potent than mitragynine and traditional opioids in some cases.
2. Unregulated Access: Consumers can unknowingly access potentially dangerous doses.
3. Misuse Potential: Individuals seeking to self-medicate or experience euphoria may misuse kratom or concentrated forms of 7-OH.
4. Lack of Quality Control: Products often lack labeling, dosage guidelines, or purity assurance.

The Need for Caution and Consultation

Despite its medicinal chemistry profile and anecdotal use in pain and mood disorder management, 7-OH is not without risks. Consumers should consult with healthcare professionals before using kratom or related compounds, especially if they are pregnant, have pre-existing health conditions, or are using other medications.

Get Connected to Help for 7-OH Abuse and Addiction

7-hydroxymitragynine, or 7-OH, is a powerful compound derived from the kratom plant that interacts with opioid receptors in ways that mimic traditional opioids like morphine. While some seek it for relief from pain, anxiety, or opioid withdrawal, the risks — including respiratory depression, dependency, and liver toxicity — make it a substance of particular concern for public health officials.

As products containing 7-OH continue to flood gas stations, smoke shops, and vape stores, often marketed through food, drink mixes, or tablets, the need for regulation, research, and public education becomes more urgent.

If you or someone you know is struggling with kratom or opioid dependence, contact Eleve Behavioral Health for support. We can help you overcome kratom and opioid addiction using evidence-based substance abuse treatment methods like medication-assisted treatment and behavioral therapy.

FAQ: Understanding 7-OH and Kratom Products

1. How can I tell if a product contains 7-OH or synthetic concentrations of it?

Most over-the-counter kratom products do not disclose specific alkaloid levels, including 7-OH. Look for third-party lab testing (COAs – Certificates of Analysis) from reputable brands. If a product boasts “extra strength,” “enhanced,” or “extract,” it’s more likely to contain synthetically concentrated levels of 7-OH or other modified compounds.

2. Are there any safe or therapeutic doses of 7-OH?

There is currently no medically approved dosage for 7-OH, and the FDA has not endorsed its therapeutic use. Because potency can vary widely between products and individuals, what is “safe” for one person may cause adverse events in another. Medical supervision is essential if kratom is being considered for any therapeutic purpose.

3. Is 7-OH addictive on its own, or only in combination with other kratom alkaloids?

Concentrated 7-OH can cause dependence and withdrawal. Other ingredients in a kratom product should not be assumed to counteract those risks. FDA advises avoiding 7-OH products and seeking professional help for opioid addiction or other health concerns.

Source: FDA · 7-OH consumer guide; product differences and safety (PDF)

4. Can 7-OH be detected in drug tests?

Standard workplace drug tests (e.g., SAMHSA 5-panel) do not screen for kratom or 7-OH. However, specialized drug testing can detect mitragynine and its metabolites, including 7-OH. These tests are often used in legal, clinical, or research settings.

5. Why is 7-OH sometimes included in kratom extracts instead of mitragynine?

Manufacturers may favor 7-OH in extracts because it delivers stronger opioid-like effects at lower doses, increasing product potency. However, this raises regulatory and health concerns, as it also increases the likelihood of side effects, dependency, and overuse.

6. Is there any medical research exploring therapeutic uses of 7-OH or kratom?

Yes, emerging research in medicinal chemistry is exploring kratom alkaloids for potential treatment of pain, opioid use disorder, and mood disorders, among others. However, these are preclinical or early-phase studies, and no formulations of kratom or 7-OH have yet received FDA approval for any medical indication.

References:

1. ACS Publications: 7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects
2. The Food and Drug Administration (FDA): 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat 
3. The Food and Drug Administration (FDA): FDA and Kratom
4. The Centers for Disease Control and Prevention (CDC): Unintentional Drug Overdose Deaths with Kratom Detected — 27 States, July 2016– December 2017
5. The National Library of Medicine (NLM): The Big Number: 1,807 calls to poison control centers about herbal supplement kratom
6. CPC Emergency Medicine: Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal